VIDEO

FindCenter AddIcon

The Remarkable Results of Microdosing: James Fadiman

By James Fadiman — 2019

In this entertaining talk from SAND18, James Fadiman, "America's wisest and most respected authority on psychedelics and their use," describes the citizen science of his recent investigations into the effects of micro dosing, and shares some fascinating stories from the hundreds he has gathered in... See more...

30:40 min

The Cost of Exclusion in Psychedelic Research

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

FindCenter AddIcon

Psychedelic Psychotherapy Is Coming: Who Will Be Included?

A new study finds widespread exclusion of minorities in psychedelic research.

FindCenter AddIcon

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

FindCenter AddIcon

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

FindCenter AddIcon

Psychedelics Shown to Ease the Effects of Racial Trauma

A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).

FindCenter AddIcon

EXPLORE TOPIC

Microdosing